Producing therapeutic peptides using biotechnology

Producing therapeutic peptides using biotechnology

Brought to you by Olon S.P.A- Olon

Overview

Synthesis of Therapeutic Peptides via Microbial Fermentation with Recombinant DNA-Technology Scenario, Challenges, Olon expertise

Key Objectives:

Biotechnology represents a unique opportunity to improve industrial process sustainability

LIMITED USE OF SOLVENTS â†’ Low environmental impact
COST EFFECTIVE APPROACH â†’ Recombinant approach is the unique SUSTAINABLE and COST COMPETITIVE process

Olon is developing a strong know-how for development of rDNA peptides and proteins.

Brought to you by:

This content was created by Olon, without editorial input from the C&EN Media Group. For more information on C&ENâ€™s custom products, visit our C&EN Media Kit .

Please complete the form to download the white paper.

Forwarded this link? Clear the form

Email Address*

Salutation*

First Name*

Last Name*

Company*

Job Title

Address 1*

City*

State*

Zip / Post Code*

Country*

Business Phone*

I would like to receive more information on products and services from the American Chemical Society

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy .